persons) are issued within 24 hours Ninety-five per cent of treatment permit from receipt of a permit application. applications to prescribe Schedule 8 medicines, Ninety-five per cent of treatment permit most of which are used to treat chronic pain (such applications to prescribe Schedule 8 medicines, as morphine, oxycodone and fentanyl) are most of which are used to treat chronic pain (such assessed within two weeks following receipt of an as morphine, oxycodone and fentanyl) are application. assessed within two weeks following receipt of an Ninety per cent of new licences and permits are application. issued for manufacture, use or supply of Ninety per cent of new licences and permits are scheduled medicines and poisons within four issued for manufacture, use or supply of weeks following receipt of required information. scheduled medicines and poisons within four Ninety per cent of treatment permits to prescribe weeks following receipt of required information. Schedule 8 medicinal cannabis are assessed and Ninety per cent of treatment permits to prescribe issued within 24 after receipt of the Schedule 8 medicinal cannabis are assessed and application and all relevant supporting material. issued within 24 hours after receipt of the Drugs and Poisons Regulation will meet these application and all relevant supporting material. performance targets by 30 June 2019. Building on the implementation of Smartforms (online Implement Smartforms for industry, research and Implement by 30 June 2019. application forms) for treatment permits, including health services. medicinal cannabis, implement Smartforms for industry, research and health services to make it easier for organisations to apply for licences and permits. Review and update the Drugs and Poisons Regulation The Drugs and Poisons Regulation website will be Reviewed and updated by 31 December 2018. website content and structure with a view to making it reviewed and both the content and format will be upgraded. This will include the application forms and easier for key external stakeholders, such as medical instructions. prescribers and industry, to navigate and locate relevant compliance related assistance and advice, such as factsheets and application forms for treatment permits.
persons) are issued within 24 hours from receipt of a permit application. Ninety-five per cent of treatment permit applications to prescribe Schedule 8 medicines, most of which are used to treat chronic pain (such as morphine, oxycodone and fentanyl) are assessed within two weeks following receipt of an application. Ninety per cent of new licences and permits are issued for manufacture, use or supply of scheduled medicines and poisons within four weeks following receipt of required information. Ninety per cent of treatment permits to prescribe Schedule 8 medicinal cannabis are assessed and issued within 24 hours after receipt of the application and all relevant supporting material. Ninety-five per cent of treatment permit applications to prescribe Schedule 8 medicines, most of which are used to treat chronic pain (such as morphine, oxycodone and fentanyl) are assessed within two weeks following receipt of an application. Ninety per cent of new licences and permits are issued for manufacture, use or supply of scheduled medicines and poisons within four weeks following receipt of required information. Ninety per cent of treatment permits to prescribe Schedule 8 medicinal cannabis are assessed and issued within 24 after receipt of the application and all relevant supporting material. Drugs and Poisons Regulation will meet these performance targets by 30 June 2019. Building on the implementation of Smartforms (online application forms) for treatment permits, including medicinal cannabis, implement Smartforms for industry, research and health services to make it easier for organisations to apply for licences and permits. Implement Smartforms for industry, research and health services. Implement by 30 June 2019. Review and update the Drugs and Poisons Regulation website content and structure with a view to making it easier for key external stakeholders, such as medical prescribers and industry, to navigate and locate relevant compliance related assistance and advice, such as factsheets and application forms for treatment permits. The Drugs and Poisons Regulation website will be reviewed and both the content and format will be upgraded. This will include the application forms and instructions. Reviewed and updated by 31 December 2018.
Drugs%20and%20poisons%20regulation%20SoE%20response%20actions%20.docx